Lesley Scott to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Lesley Scott has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0,246
-
High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia. Leukemia. 2016 06; 30(6):1273-81.
Score: 0,127
-
Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients. Leukemia. 2015 Jul; 29(7):1514-23.
Score: 0,119